Baili Chen

机构：Sun Yat-sen University, Chinese Academy of Sciences, Northwest Institute of Eco-Environment and Resources, The First Affiliated Hospital, Sun Yat-sen University, University of Chinese Academy of Sciences, Beijing Sport University · ORCID：0000-0002-7905-9499

发表论文 169 篇 · 总被引 3540 次 · h-index 33

代表论文

• Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study (2024 · The Lancet · 被引 107)
• Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies (2024 · The Lancet · 被引 95)
• Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study (2024 · United European Gastroenterology Journal · 被引 25)
• Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cells (2024 · Acta Pharmaceutica Sinica B · 被引 20)
• Oasis sustainability is related to water supply mode (2023 · Agricultural Water Management · 被引 17)
• Impact of Altitude Training on Athletes’ Aerobic Capacity: A Systematic Review and Meta-Analysis (2025 · Life · 被引 14)